Timeline
Pharma
Genflow wins Japanese patent allowance for SIRT6 therapy
Scancell widens annual loss
Sareum signals intention to launch equity capital raise
MedPal AI confirms no equity raise planned as it seeks working capital facility
Futura Medical reports stronger user results for optimised Eroxon Intense
Health & Bio Today: Avacta, Cambridge Cognition, MedPal AI, Smith+Nephew, Poolbeg Pharma, OKYO Pharma
Smith+Nephew brings cartilage repair implant to Europe
OKYO Pharma enrolls first patients in Phase 3 neuropathic corneal pain trial
Cambridge Cognition joins NHS study on earlier Alzheimer's diagnosis
Poolbeg Pharma secures South Korean patent for POLB 001
Avacta raises £12.5m in placing and subscription
Health & Bio Today: Fusion Antibodies refreshes platform after margin turnaround, Molecule Group
Fusion Antibodies relaunches website to sharpen customer focus
IXICO presents Parkinson's imaging research at European conference
Imaging Biometrics builds US pipeline, rebrands core platform as IB Vista
PHP rental growth outpaces guidance as joint venture deals progress
Eden Research wins US label expansion for Mevalone
GENinCode revenue halves as NHS cutbacks bite
Solvonis says SVN-001 outperforms rivals on key AUD endpoint
Incanthera raises £355,000 through convertible loan notes
Thalia Therapeutics wins Chinese patent for miRisten
Ondine partners with Mela Solutions to speed NHS Steriwave adoption
AstraZeneca invests $2bn in Summit for cancer drug alliance
Eden Research flags insecticide and blight pipeline progress
Abingdon Health lab wins ISO/IEC 17025 accreditation
Incanthera confirms first half revenue was well short of target
Poolbeg dosed eight patients as TOPICAL trial gains momentum
4basebio extends pharma tie-up into cell therapy
Zenith Energy buys two more solar sites
Poolbeg doses eight patients in POLB 001 CRS trial
Upland's LSOG project begins gas pipeline construction
Thalia completes chemistry synthesis for cardiovascular RNA drug
Avacta unveils new AVA6103 data at pancreatic cancer conference
Abingdon Health opens US manufacturing hub in Wisconsin
BSF Enterprise wins US patent allowance for ETSYL collagen tech
Cordiant Digital Infrastructure signs AI contracts as pipeline tops £1bn
Ondine's Steriwave rolls out across five Ontario hospitals
AstraZeneca wins EU approval for Trixeo in asthma
PureTech Health reports $220m cash as portfolio hits key milestones
SkinBioTherapeutics confirms leadership, guides revenue up 20.5%
The Premarket Brief: Smiths Group, SThree, Kingfisher, Oxford Biomedica, PCI-Pal, Metlen, Rentokil Initial
Oxford Biomedica reiterates guidance as H1 revenue rises
Health & Bio Today: Crism Therapeutics doses first glioblastoma patients, AstraZeneca, Verici Dx, PureTech Health, Coiled Therapeutics
Crism Therapeutics doses first patients in Phase 2 glioblastoma trial
PureTech's Gallop wins FDA Fast Track for LYT-200
Verici Dx sets Q4 launch for transplant gene test
AstraZeneca's Enhertu wins EU backing for early breast cancer
AstraZeneca's gefurulimab wins CHMP backing for gMG
ECO Animal Health clears US safety hurdle for poultry vaccine
Companies in Pharma
- AstraZeneca LSE:AZN
- GSK GSK
- Bsf Enterprise BSFA
- Futura Medical FUM
- Solvonis Therapeutics SVNS
- Eco Animal Health AIM:EAH
- Novo Nordisk NVO
- Thalia Therapeutics LSE:THAT
- Beximco Pharmaceuticals LSE:BXP
- Nuformix LSE:NFX
- Eli Lilly LLY
- Hikma Pharmaceuticals LSE:HIK
- Novo Nordisk A/S 0QIU
- Avere Therapeutics Nasdaq:AVRX
- Kailera Nasdaq:KLRA